| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.0005 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |